HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

TORONTO, May 16, 2024 (GLOBE NEWSWIRE) — HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX:AIDX) (OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that it has participated in recently published leading-edge research on Chronic Kidney Disease (“CKD”) in the esteemed American Journal of Kidney Diseases (“AJKD”). HEALWELL’s AI-powered clinical decision support Co-Pilot technology paired with a highly accurate machine model for CKD progression supports US-based Nephrologists to improve guideline recommended testing in CKD patients. This marks a significant validation of the capability of such advanced technology in chronic diseases; an area of particular importance due to the burden of chronic diseases including CKD on the North American population.  HEALWELL’s recently launched second-generation AI Clinical Co-Pilot incorporates similar advanced technology to support physicians with improved patient care.

Read more at globenewswire.com